FDA NDC Directory · JSON-LD · Markdown

ORENCIA

NDC 0003-2187 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameabatacept
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryBiologic License Application · App BLA125118
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsABATACEPT (250 mg/15mL)
Marketing started20090101
Package count1

External sources

Source: openFDA. Public-domain (CC0).